Poseida Therapeutics: Global Collaboration Agreement With Roche
Poseida announced a strategic global collaboration agreement with Roche potentially worth up to $6 billion. See why I feel PSTX stock appears undervalued.
Source: seekingalpha.com
Stay updated with breaking news from Takeda Poseida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poseida announced a strategic global collaboration agreement with Roche potentially worth up to $6 billion. See why I feel PSTX stock appears undervalued.
The progress of gene therapies continues to be stymied by safety risks associated with the viruses used to deliver them. Takeda Pharmaceutical is partnering with Poseida Therapeutics in a bet that the biotech’s non-viral technologies could offer a safer alternative.